Phathom Pharmaceuticals, Inc.

This study aimed to understand how well the body absorbs two new dissolving tablet versions of the drug vonoprazan, which treats heartburn and stomach acid problems. Researchers compared these new forms—taken with or without water or via a syringe—to a standard tablet. The study …